Patents by Inventor Sarah Stidham

Sarah Stidham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11034963
    Abstract: The present application discloses nucleic acid aptamer based signaling polynucleotides (SPNs) that specifically bind an allergen protein. Provided in the present invention include aptamers, SPNs, SPN-complement complexes, magnetic particle conjugates, DNA printed glass slides and detection agents, and detection methods using the same for detecting the presence, or absence of an allergen protein in a food sample.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: June 15, 2021
    Assignee: DOTS TECHNOLOGY CORP.
    Inventors: Adi Gilboa-Geffen, Valerie Villareal, Sarah Stidham, Morris Nehama
  • Publication number: 20210109076
    Abstract: The present invention provides systems, devices, signaling polynucleotides (SPNs), detection agents and methods for detecting the presence and/or absence of one or more allergens in a sample particularly a food sample. The detection system includes a separate sampler, at least one disposable detection vessel for receiving and processing a test sample and a detection device for measuring a fluorescent signal. SPNs derived from aptamer that bind allergens are provided as detection agents. SPNs have a single open structure, and are labeled with a fluorophore. Changes in fluorescence polarization of SPNs upon the binding of allergens are measured to calculate the allergen content in a sample.
    Type: Application
    Filed: December 21, 2020
    Publication date: April 15, 2021
    Inventors: Adi Gilboa-Geffen, Renuka Babu Brown, Sarah Stidham, Valerie Villareal, Adam J. Young, Joshua Glenn Anthony, Patrick Murphy, John H. Kepler, Adam Jacobs
  • Patent number: 10908139
    Abstract: The present invention provides systems, devices, signaling polynucleotides (SPNs), detection agents and methods for detecting the presence and/or absence of one or more allergens in a sample particularly a food sample. The detection system includes a separate sampler, at least one disposable detection vessel for receiving and processing a test sample and a detection device for measuring a fluorescent signal. SPNs derived from aptamer that bind allergens are provided as detection agents. SPNs have a single open structure, and are labeled with a fluorophore. Changes in fluorescence polarization of SPNs upon the binding of allergens are measured to calculate the allergen content in a sample.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: February 2, 2021
    Assignee: DOTS TECHNOLOGY CORP.
    Inventors: Adi Gilboa-Geffen, Renuka Babu Brown, Sarah Stidham, Valerie Villareal, Adam J. Young, Joshua Glenn Anthony, Patrick Murphy, John H. Kepler, Adam Jacobs
  • Publication number: 20190292544
    Abstract: The present application discloses nucleic acid aptamer based signaling polynucleotides (SPNs) that specifically bind an allergen protein. Provided in the present invention include aptamers, SPNs, SPN-complement complexes, magnetic particle conjugates, DNA printed glass slides and detection agents, and detection methods using the same for detecting the presence, or absence of an allergen protein in a food sample.
    Type: Application
    Filed: November 8, 2017
    Publication date: September 26, 2019
    Inventors: Adi Gilboa-Geffen, Valerie Villareal, Sarah Stidham, Morris Nehama
  • Publication number: 20190079063
    Abstract: The present invention provides systems, devices, signaling polynucleotides (SPNs), detection agents and methods for detecting the presence and/or absence of one or more allergens in a sample particularly a food sample. The detection system includes a separate sampler, at least one disposable detection vessel for receiving and processing a test sample and a detection device for measuring a fluorescent signal. SPNs derived from aptamer that bind allergens are provided as detection agents. SPNs have a single open structure, and are labeled with a fluorophore. Changes in fluorescence polarization of SPNs upon the binding of allergens are measured to calculate the allergen content in a sample.
    Type: Application
    Filed: March 10, 2017
    Publication date: March 14, 2019
    Inventors: Adi Gilboa-Geffen, Renuka Babu Brown, Sarah Stidham, Valerie Villareal, Adam J. Young, Joshua Glenn Anthony, Patrick Murphy, John H. Kepler, Adam Jacobs